Whether or not this can even be accomplished is uncertain at this time and represents one of the forefronts of research into GHI vaccines.What IS known is that the many Herpes vaccines that have been produced, almost without exception, generate very strong immune responses in the animals and humans to which they are given.They do NOT eradicate the virus from the body, however, and do not prevent recurrences.Numerous articles have suggested that these European vaccines also reduce transmission of GHI to non-infected partners. Read this carefully, though, before you consider booking a flight: It is difficult to separate out from the effect of the vaccine the other effect of “patient counseling”, that is, being “smart” about managing GHI.
The Bottom Line: There MAY be some benefit from these vaccines to reducing recurrence frequency.
Interestingly, numerous studies have indicated a dramatic presence of anti-Herpes antibody in the vaginal fluids of vaccinated animals.
This fact will likely be one of the key players in the future of controlling infections for females.
That alone would decrease the transmission rate, as it should.
A vaccine uses a product of the body’s immune system to kill virus particles, either antibody (liquid protein floating around in the blood and body fluid) which is directly targeted toward proteins on the virus, OR lymphocytes (white blood cells that are turned on by the immune system to fight infection) that are targeted toward some of the same proteins on the virus.
H., Medical Director 50 million Americans have GHI (genital herpes infections).